Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i> -Mutant Lung CancerAdam J. Schoenfeld, Helena A. Yu, Paul K. Paik et al.|Clinical Cancer Research|2020Cited by 381
Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung CancersMorana Vojnic, Marc Ladanyi, Michael Offin et al.|Journal of Thoracic Oncology|2019Cited by 97
Clinical Relevance and Therapeutic Significance of MicroRNA-133a Expression Profiles and Functions in Malignant Osteosarcoma-Initiating CellsTomohiro Fujiwara, Takahiro Ochiya, Nobuyoshi Kosaka et al.|Stem Cells|2013Cited by 72